LENSAR, Inc. (LNSR)

Market Cap	163.99M
Revenue (ttm)	53.49M
Net Income (ttm)	-31.40M
Shares Out	11.79M
EPS (ttm)	-2.73
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,445
Open	13.79
Previous Close	13.75
Day's Range	13.78 - 13.93
52-Week Range	2.95 - 17.31
Beta	0.56
Analysts	Hold
Price Target	15.00 (+7.91%)
Earnings Date	May 8, 2025

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 140
• Stock Exchange: NASDAQ
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2024, LENSAR's revenue was $53.49 million, an increase of 26.87% compared to the previous year's $42.16 million. Losses were -$31.40 million, 118.3% more than in 2023.

Analyst Forecast

According to one analyst, the rating for LNSR stock is "Hold" and the 12-month stock price forecast is $15.0.

Price Target

$15.0

(7.91% upside)

Analyst Consensus: Hold